Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Robert MacLaren to Intensive Care Units

This is a "connection" page, showing publications Robert MacLaren has written about Intensive Care Units.

 
Connection Strength
 
 
 
5.447
 
  1. MacLaren R, Brophy GM. Prevention Strategies to Improve Outcomes in Critically Ill Adults. Pharmacotherapy. 2019 03; 39(3):212-214.
    View in: PubMed
    Score: 0.478
  2. Reynolds PM, MacLaren R. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis. Pharmacotherapy. 2019 03; 39(3):408-420.
    View in: PubMed
    Score: 0.461
  3. MacLaren R, Campbell J. The authors reply. Crit Care Med. 2014 Sep; 42(9):e637-8.
    View in: PubMed
    Score: 0.349
  4. MacLaren R, Campbell J. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. Crit Care Med. 2014 Apr; 42(4):809-15.
    View in: PubMed
    Score: 0.339
  5. MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014 Apr; 174(4):564-74.
    View in: PubMed
    Score: 0.339
  6. MacLaren R, Brett McQueen R, Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. Pharmacotherapy. 2013 Apr; 33(4):401-10.
    View in: PubMed
    Score: 0.315
  7. MacLaren R, Forrest LK, Kiser TH. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy. 2007 Mar; 27(3):351-9.
    View in: PubMed
    Score: 0.207
  8. MacLaren R, Sullivan PW. Economic evaluation of sustained sedation/analgesia in the intensive care unit. Expert Opin Pharmacother. 2006 Oct; 7(15):2047-68.
    View in: PubMed
    Score: 0.202
  9. Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006 Apr; 40(4):612-8.
    View in: PubMed
    Score: 0.195
  10. MacLaren R, Sullivan PW. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. Value Health. 2005 Mar-Apr; 8(2):105-16.
    View in: PubMed
    Score: 0.181
  11. Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004 Jun; 57(2):105-11.
    View in: PubMed
    Score: 0.171
  12. Reynolds PM, Wells L, Powell M, MacLaren R. Associated Mortality Risk of Proton Pump Inhibitor Therapy for the Prevention of Stress Ulceration in Intensive Care Unit Patients: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2023 07 01; 57(6):586-594.
    View in: PubMed
    Score: 0.161
  13. Buckley MS, Kobic E, Yerondopoulos M, Sharif AS, Benanti GE, Meckel J, Puebla Neira D, Boettcher SR, Khan AA, McNierney DA, MacLaren R. Comparison of Methicillin-Resistant Staphylococcus aureus Nasal Screening Predictive Value in the Intensive Care Unit and General Ward. Ann Pharmacother. 2023 09; 57(9):1036-1043.
    View in: PubMed
    Score: 0.155
  14. Bradley M, Kiser TH, Mueller SW, Reynolds PM, MacLaren R. Correlation Between and Nursing Satisfaction With CIWA-Ar, mMINDS, and SEWS Scoring Tools for the Assessment of Severe Alcohol Withdrawal Syndrome in ICU Patients. Ann Pharmacother. 2023 02; 57(2):175-183.
    View in: PubMed
    Score: 0.150
  15. Boyd C, Hassig T, MacLaren R. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU. Pharmacotherapy. 2021 10; 41(10):820-827.
    View in: PubMed
    Score: 0.142
  16. Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, Stollings JL, Gross K, Foos SA, Roberts RJ, Acquisto NM, Taylor S, Bentley M, Jacobi J, Meyer TA. Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update. Crit Care Med. 2020 09; 48(9):1375-1382.
    View in: PubMed
    Score: 0.132
  17. Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, Stollings JL, Gross K, Foos SA, Roberts RJ, Acquisto NM, Taylor S, Bentley M, Jacobi J, Meyer TA. Position Paper on Critical Care Pharmacy Services: 2020 Update. Crit Care Med. 2020 09; 48(9):e813-e834.
    View in: PubMed
    Score: 0.132
  18. MacLaren R, Devlin JW. The Bedside Critical Care Pharmacist: A Mandatory ICU Team Member Essential for Patient Care. Crit Care Med. 2019 09; 47(9):1276-1278.
    View in: PubMed
    Score: 0.123
  19. Baumgartner L, Townsend N, Winkelman K, MacLaren R. CE: Original Research: The Efficacy and Safety of an RN-Driven Ketamine Protocol for Adjunctive Analgesia During Burn Wound Care. Am J Nurs. 2018 Jul; 118(7):26-31.
    View in: PubMed
    Score: 0.114
  20. Parikh L, MacLaren R. The predictive performances of equations used to estimate unbound phenytoin concentrations in a medical ICU population and the impact of exogenous albumin administration. J Crit Care. 2018 04; 44:95-100.
    View in: PubMed
    Score: 0.108
  21. MacLaren R. Measuring Gastric Emptying in the Critically Ill: More Than a Gut Feeling. JPEN J Parenter Enteral Nutr. 2017 09; 41(7):1087-1089.
    View in: PubMed
    Score: 0.103
  22. Beyer JT, Schoeppler KE, Zanotti G, Weiss GM, Mueller SW, MacLaren R, Fish DN, Kiser TH. Antithrombin Administration During Intravenous Heparin Anticoagulation in the Intensive Care Unit: A Single-Center Matched Retrospective Cohort Study. Clin Appl Thromb Hemost. 2018 Jan; 24(1):145-150.
    View in: PubMed
    Score: 0.100
  23. Preslaski CR, Mueller SW, Kiser TH, Fish DN, MacLaren R. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit. J Clin Pharm Ther. 2014 Dec; 39(6):658-62.
    View in: PubMed
    Score: 0.088
  24. Mueller SW, Preslaski CR, Kiser TH, Fish DN, Lavelle JC, Malkoski SP, MacLaren R. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014 May; 42(5):1131-9.
    View in: PubMed
    Score: 0.085
  25. MacLaren R, Preslaski CR, Mueller SW, Kiser TH, Fish DN, Lavelle JC, Malkoski SP. A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes. J Intensive Care Med. 2015 Mar; 30(3):167-75.
    View in: PubMed
    Score: 0.083
  26. Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013 Nov; 144(5):1687-1695.
    View in: PubMed
    Score: 0.082
  27. Horinek EL, Kiser TH, Fish DN, MacLaren R. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009 Dec; 43(12):1964-71.
    View in: PubMed
    Score: 0.063
  28. MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009 Jul; 29(7):761-8.
    View in: PubMed
    Score: 0.061
  29. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008 Dec; 36(12):3184-9.
    View in: PubMed
    Score: 0.059
  30. Owen P, Monahan MF, MacLaren R. Implementing and assessing an evidence-based electrolyte dosing order form in the medical ICU. Intensive Crit Care Nurs. 2008 Feb; 24(1):8-19.
    View in: PubMed
    Score: 0.053
  31. Dugan HA, MacLaren R, Jung R. Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units. J Clin Pharm Ther. 2003 Apr; 28(2):123-9.
    View in: PubMed
    Score: 0.040
  32. MacLaren R. Intolerance to intragastric enteral nutrition in critically ill patients: complications and management. Pharmacotherapy. 2000 Dec; 20(12):1486-98.
    View in: PubMed
    Score: 0.034
  33. MacLaren R, Plamondon JM, Ramsay KB, Rocker GM, Patrick WD, Hall RI. A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy. 2000 Jun; 20(6):662-72.
    View in: PubMed
    Score: 0.032
  34. Buckley MS, Agarwal SK, MacLaren R, Kane-Gill SL. Adverse Hemodynamic Events Associated With Concomitant Dexmedetomidine and Propofol for Sedation in Mechanically Ventilated ICU Patients. J Intensive Care Med. 2020 Dec; 35(12):1536-1545.
    View in: PubMed
    Score: 0.031
  35. Morris AA, Page RL, Baumgartner LJ, Mueller SW, MacLaren R, Fish DN, Kiser TH. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions. J Intensive Care Med. 2017 Oct; 32(9):547-553.
    View in: PubMed
    Score: 0.025
  36. VanderWeide LA, Foster CJ, MacLaren R, Kiser TH, Fish DN, Mueller SW. Evaluation of Early Dexmedetomidine Addition to the Standard of Care for Severe Alcohol Withdrawal in the ICU: A Retrospective Controlled Cohort Study. J Intensive Care Med. 2016 Mar; 31(3):198-204.
    View in: PubMed
    Score: 0.022
  37. Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care. 2014 Dec; 29(6):955-60.
    View in: PubMed
    Score: 0.022
  38. Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother. 2004 Dec; 48(12):4606-10.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)